Immunic
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -33 | -42 | -43 | |
EBITDA | -32,555 | -19,258 | -25,539 | -26,777 |
EBIT | -32,588 | -19,300 | -25,579 | -26,820 |
Net Income | -32,588 | -19,300 | -25,579 | -26,820 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -17,303 | -19,292 | -20,207 | -24,645 |
Cash | 186,629 | 15,483 | 35,132 | 55,310 |
Basic Shares | 30,136 | 15,568 | 19,389 | 13,217 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -168 | -134 | -111 | -77 |
EBITDA | -97,004 | -100,373 | -93,501 | -86,441 |
EBIT | -97,172 | -100,507 | -93,612 | -86,518 |
Net Income | -97,172 | -100,507 | -93,612 | -120,407 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 20,875 | |||
Free Cash Flow | -85,967 | -85,030 | -71,162 | -65,256 |
Cash | 15,483 | 35,668 | 46,674 | 106,745 |
Basic Shares | 15,568 | 10,017 | 4,432 | 3,181 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$1.08 |
2025-12-31 | -$0.12 |
2025-09-30 | -$1.30 |
2025-06-30 | -$0.20 |